What is the intrinsic value of FBIO?
As of 2025-12-14, the Intrinsic Value of Fortress Biotech Inc (FBIO) is
0.64 USD. This FBIO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.93 USD, the upside of Fortress Biotech Inc is
-78.08%.
Is FBIO undervalued or overvalued?
Based on its market price of 2.93 USD and our intrinsic valuation, Fortress Biotech Inc (FBIO) is overvalued by 78.08%.
FBIO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(432.13) - (129.48) |
(197.11) |
-6827.1% |
| DCF (Growth 10y) |
(196.78) - (649.76) |
(298.62) |
-10291.8% |
| DCF (EBITDA 5y) |
(120.70) - (157.50) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(186.42) - (268.32) |
(1,234.50) |
-123450.0% |
| Fair Value |
0.64 - 0.64 |
0.64 |
-78.08% |
| P/E |
2.37 - 4.03 |
3.00 |
2.5% |
| EV/EBITDA |
(44.83) - (30.89) |
(48.32) |
-1749.0% |
| EPV |
(43.30) - (65.64) |
(54.47) |
-1959.1% |
| DDM - Stable |
1.24 - 4.66 |
2.95 |
0.8% |
| DDM - Multi |
(124.55) - (361.51) |
(184.97) |
-6413.1% |
FBIO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
90.95 |
| Beta |
0.82 |
| Outstanding shares (mil) |
31.04 |
| Enterprise Value (mil) |
58.13 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.86% |
| Cost of Debt |
9.54% |
| WACC |
9.12% |